A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Clinical trial NCT00931762 · TERMINATED

Trial details

NCT number: NCT00931762
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-Polycythemia Vera Post-Essential Thrombocytopenia

Start date: 2009-08-31
Primary completion: 2011-08-29
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.